bioRxiv/medRxiv TRiP Review Activity

413 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 30: Articles 291-300  | Next

Suppression of endothelial miR-22-3p mediates non-small cell lung cancer cell-induced angiogenesis
Gu, Y., Pais, G., Becker, V., Körbel, C., Ampofo, E., Ebert, E., Hohneck, J., Ludwig, N., Meese, E., Bohle, R. M., Zhao, Y., Menger, M. D., Laschke, M. W.
10.1101/2021.04.04.438401 — Posted: 2021-04-06 — Discussion: 2022-07-09  eLife
DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness
Carrier, A., Desjobert, C., Ponger, L., Lamant, L., Bustos, M., Torres-Ferreira, J., Henrique, R., Jeronimo, C., Lanfrancone, L., Delmas, A., Favre, G., Delaunay, A., Busato, F., Hoon, D. S. B., Tost, J., Etievant, C., Riond, J., Arimondo, P. B.
10.1101/2022.04.11.487909 — Posted: 2022-04-12 — Discussion: 2022-07-07  eLife
Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutations
Choudhary, G., Pellagatti, A., Agianian, B., Smith, M., Bhagat, T. D., Gordon-Mitchell, S., Pandey, S., Shah, N., Aluri, S., Schwartz, L., Steeples, V., Booher, R., Ramachandra, M., Samson, M., Carbajal, M., Pradhan, K., Bowman, T., Pillai, M. M., Will, B., Wickrema, A., Shastri, A., Bradley, R. K., Martell, R. E., Steidl, U., Gavathiotis, E., Boultwood, J., Starczynowski, D. T., Verma, A.
10.1101/2022.03.09.483595 — Posted: 2022-03-09 — Discussion: 2022-07-05  eLife
Arbidol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase
Liu, K., Dong, Z., Yang, N., Lu, X., Jiang, Y., Zhao, L., Wang, D., Wei, Y., Yu, Y., Kim, M. O., Laster, K. V., Li, X., Yuan, B.
10.1101/2022.02.15.480509 — Posted: 2022-02-18 — Discussion: 2022-06-21  eLife
Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgery
Sipe, L. M., Chaib, M., Korba, E. B., Lovely, M. C., Jo, H., Counts, B. R., Tanveer, U., Clements, J. C., John, N. A., Daria, D., Marion, T. N., Sekhri, R., Pingili, A. K., Teng, B., Carson, J. A., Hayes, D. N., Davis, M. J., Pierre, J. F., Makowski, L.
10.1101/2022.03.30.486293 — Posted: 2022-04-01 — Discussion: 2022-06-16  eLife
GPR183 mediates the capacity of the novel CD47-CD19 bispecific antibody TG-1801 to heighten ublituximab-umbralisib (U2) anti-lymphoma activity
Ribeiro, M., Profitos-Peleja, N., Santos, J. C., Blecua, P., Reyes Garau, D., Armengol, M., Fernandez-Serrano, M., Miskin, H. P., Bosch, F., Esteller, M., Normant, E., Roue, G.
10.1101/2022.03.31.486558 — Posted: 2022-04-01 — Discussion: 2022-06-13  eLife
WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation
Yan, Q., Chen, J. F.-Y., Cai, W., Chen, H., Wingrove, E., Kurley, S., Chan, L. H., Zhang, M., Arnal-Estape, A., Zhao, M., Balabaki, A., Li, W., Yu, X., Dou, Y., Liu, Y., Jin, J., Westbrook, T. F., Nguyen, D.
10.1101/2022.03.30.486357 — Posted: 2022-03-30 — Discussion: 2022-06-13  eLife
Inducible lncRNA transgenic mice reveal continual role of HOTAIR in promoting breast cancer metastasis
Ma, Q., Yang, L., Tolentino, K., Zhao, Y., Lizenburger, U. M., Shi, Q., Zhu, L., Tsai, M.-C., Chen, J.-A., Lai, I., Zeng, H., Li, L., Chang, H.
10.1101/2022.04.21.488980 — Posted: 2022-04-22 — Discussion: 2022-06-10  eLife
Genetic and compound screens uncover factors modulating cancer cell response to indisulam
Pogacar, Z., Groot, K., Jochems, F., Dos Santos Dias, M., Morris, B., Roosen, M., Wardak, L., De Conti, G., Velds, A., Lieftink, C., Beijersbergen, R. L., Bernards, R., Leite de Oliveira, R.
10.1101/2021.12.20.473451 — Posted: 2021-12-21 — Discussion: 2022-06-02  EMBO Press
Confined migration promotes cancer metastasis through resistance to anoikis and increased invasiveness
Fanfone, D., Wu, Z. C., Mammi, J., Berthenet, K., Neves, D., Weber, K., Halaburkova, A., Virard, F., Bunel, F., Hernandez-Vargas, H., Tait, S. W., Hennino, A., Ichim, G.
10.1101/2021.08.17.456592 — Posted: 2021-08-17 — Discussion: 2022-05-28  eLife

Evaluation Sources